Filing Details
- Accession Number:
- 0001225208-21-010901
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-27 20:28:48
- Reporting Period:
- 2021-07-27
- Accepted Time:
- 2021-07-27 20:28:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1801586 | Meghan Scanlon | 300 Boston Scientific Way Marlborough MA 01752-1234 | Svp,Pres,Urology Pelvic Health | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-07-27 | 13,850 | $23.41 | 32,992 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-07-27 | 13,850 | $45.01 | 19,142 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2021-07-27 | 13,850 | $0.00 | 13,850 | $23.41 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2026-07-01 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
- Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- Represents the weighted average sale price. These shares were sold in multiple transactions at $45.00 and $45.02. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Grant to the reporting person of an option to purchase 13,850 shares of common stock vesting in four equal annual installments beginning on July 1, 2017, the first anniversaryof the date of grant.